Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
3
×
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
3
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
3
×
texas blog main
texas top stories
venture capital
3
×
wisconsin blog main
wisconsin top stories
biogen
boston top stories
clinical trials
deals
deerfield management
europe blog main
europe top stories
gilead sciences
ipo
melinta therapeutics
What
bio
roundup
covid
fda
ipo
medicines
acquisitions
activity
ahead
announced
approvals
asco
biogen
branded
ceo
choices
clamped
collabs
commissioner
consumers
costly
counterweight
daniel
deal
delays
developing
drugs
economic
elevatebio
fast
generic
gilead
gilead’s
graft
help
including
introduce
isn’t
lot
medications
Language
unset
Current search:
cancer
×
startups
×
" venture capital "
×
biotech
×
" indiana top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More